EWM
GILD icon

Evolution Wealth Management’s Gilead Sciences GILD Stock Holding History

Evolution Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.67K Buy
55
+32
+139% +$4.48K 0.01% 551
2025
Q4 		$2.82K Sell
23
-36
-61% -$4.38K ﹤0.01% 614
2025
Q3 		$6.6K Sell
59
-37
-39% -$4.21K 0.01% 410
2025
Q2 		$10.7K Buy
+96
New +$10.2K 0.01% 350

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Evolution Wealth Management's GILD Position: Q1 2026 in Review

Evolution Wealth Management increased its Gilead Sciences (GILD) stake by 139% in Q1 2026, buying an estimated $4.48K and bringing the position to 55 shares worth $7.67K. The position accounts for 0.01% of the portfolio, ranked #551.

Evolution Wealth Management first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $10.7K in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Evolution Wealth Management held 55 shares of Gilead Sciences worth $7.67K as of Q1 2026.
  • Evolution Wealth Management bought 32 Gilead Sciences shares in Q1 2026, an estimated $4.48K.
  • Gilead Sciences made up 0.01% of Evolution Wealth Management's portfolio in Q1 2026, its #551 holding.
  • Evolution Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • Evolution Wealth Management's Gilead Sciences position peaked at $10.7K in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Evolution Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.